Filing Details

Accession Number:
0001209191-13-048990
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-10-23 12:44:24
Reporting Period:
2013-10-22
Filing Date:
2013-10-23
Accepted Time:
2013-10-23 12:44:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368514 Adma Biologics Inc. NONE Biological Products, (No Disgnostic Substances) (2836) 562590442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1526880 Burrill Capital Fund Iv, L.p. One Embarcadero Center
Suite 2700
San Francisco CA 94111
No No Yes No
1542967 Burrill & Co (Bcf Iv Gp), Llc One Embarcadero Center
Suite 2700
San Francisco CA 94111
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2013-10-22 308,824 $8.50 1,433,304 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. These shares are held of record by Burrill Capital Fund IV, L.P ("Burrill") and are deemed to be beneficially owned by Burrill & Company (BCF IV GP), LLC ("Burrill GP"), and each of the individual managing members of Burrill GP. The individual managing members of Burrill GP are G. Steven Burrill and David S. Wetherell (the "Managers"). Burrill GP and the Managers may share voting and dispositive power over the shares owned of record by Burrill. Burrill GP and the Managers disclaim beneficial ownership over such shares except to the extent of their respective pecuniary interest therein.